Redcare Pharmacy NV provided earnings guidance for the full year 2023. For the year, the company confirmed the guidance of net sales EUR 1.7 billion to EUR 1.8 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
109.5 EUR | -9.13% | -11.48% | -16.79% |
26/04 | REDCARE PHARMACY : Deutsche Bank reiterates its Buy rating | ZD |
26/04 | REDCARE PHARMACY : Hauck & Aufhauser keeps its Buy rating | ZD |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.79% | 2.42B | |
-30.37% | 15.68B | |
-22.51% | 12.39B | |
-22.88% | 6.74B | |
-6.01% | 6.29B | |
+11.76% | 6.26B | |
+70.00% | 4.95B | |
-1.90% | 4.7B | |
-5.58% | 4.03B | |
-7.87% | 3.62B |
- Stock Market
- Equities
- RDC Stock
- News Redcare Pharmacy NV
- Redcare Pharmacy NV Provides Earnings Guidance for the Full Year 2023